Applied DNA Sciences

Sales soar, but MSC can’t manufacture a winning 2Q

  MSC INDUSTRIAL SUPPLY CO. Headquarters: Melville Industry: Capital goods NYSE: MSM Reporting Date: April 10, 2019 Reporting Quarter: 2Q FY2019 Quarter Ended: March 31, 2019 Numbers: Net second-quarter sales were reported as $823 million, a 7 percent increase over the $769 million reported for the same quarter last fiscal year. However, quarterly net income declined sharply year-over-year, down 41.8 percent to $68.4 million, and diluted earnings per share followed, dropping 39.8 percent to $1.24….


No. 394: On cancer centers, secure weed and Asian affairs (plus: naughty books in Huntington)

  Don’t know how you do it: But you’ve done it again, dear reader – it’s Friday and you’re sprinting toward the finish line of another busy workweek, with another well-earned weekend in the offing. Nicely done. It’s April 5 out there, and if you had Alexander Nevsky’s Russian forces turning back the Teutonic Knights in the Battle on the Ice on this date in 1242, pozdravlyayu! The state gratefully collects 200 rubles on your…


Breakfast of champions

Hundreds turn out to honor LI’s brightest innovators (photos by Bob Giglione) In a rare breakfast networker that delivered all the feels, Innovate Long Island saluted its 2019 Innovators of the Year Tuesday at the Crest Hollow Country Club in Woodbury. More than 200 guests turned out to honor two dozen of Long Island’s brightest and boldest researchers, inventors, entrepreneurs and executives, including 2019 Master of Innovation Mitch Maiman and Stony Brook University Vice President…


No. 381: The Spur evolves, MIDI steps up, Applied DNA in the weeds – and Amazon, we hardly knew ye

  Well done: It’s Friday, friends, and you’ve done it again – the end of the workweek is upon us and another welcomed weekend dawns. It’s Feb. 15 out there, and it’s a busy one – Liberation Day in Afghanistan, National Flag Day in Canada, Statehood Day in Serbia, Total Defence Day in Singapore and, here in the States, Susan B. Anthony Day, celebrating the life and times of our national matriarch of women’s suffrage…


New licensing deal adds fresh buzz to joint venture

By GREGORY ZELLER // A partnership between a Stony Brook biotech and a Canadian pharmaceutical-solutions provider is growing like a weed. Less than a year since introducing the world’s first DNA-based cannabis-tagging system and just five months since they upgraded the system to accommodate large-scale growers, Applied DNA Sciences and Canadian/Panamanian cohort TheraCann International Benchmark Corp. have inked an exclusive licensing deal. The skinny: a long-term licensing agreement pairing Applied DNA’s proprietary CertainT supply chain…


No. 378: Applied DNA in Asia, tech in the classroom and golfers on the moon (plus: why King Kullen still cares)

  Stuck in the middle with you: Here we are, dear reader, together again at the midpoint of another busy week of socioeconomic innovation. Welcome to Wednesday! It’s Feb. 6 out there, marking both Ronald Reagan Day in California (where the future president served two terms as governor) and the UN’s International Day of Zero Tolerance for Female Genital Mutilation, which is no joke. Sick days: Before we get started, yes, you have the flu…


Globetrotting Applied DNA has it made in Taiwan

By GREGORY ZELLER // Look out, Asia – here comes Applied DNA Sciences. Picking up where it left off at the end of a hyper-busy 2018 – in which it expanded its DNA-based supply-chain-authentication portfolio to include pharmaceuticals manufacturing in Pennsylvania, legalized marijuana distribution in Canada and a host of other supply chains in domestic and international markets – the Stony Brook-based biotech is sending its product-traceability solutions deep into to “the heart of Asia’s…


No: 365: Electrons, hackathons, gadget gifts and yes, America, there is a climate change

  Golden mettle: Congratulations, dear reader – you’ve reached the 50th Friday of 2018 (go ahead and count, if you don’t believe us) and the end of another busy week of socioeconomic innovation. You are to be commended. It’s Dec. 14 out there, and we have plenty of interesting days to choose from – it’s international Monkey Day and, here in the USA, National Salesperson Day. Because it just sounds so badass: But we’re going…


No. 353: Don’t be scared, it’s just our Halloween edition (featuring spacemen, blood machines and ghost chickens)

  In the spirit: Welcome to Wednesday, fearless readers, the midpoint of another busy week of socioeconomic innovation and the start of another holiday season. It is, of course, Oct. 31, a date that needs no introduction – though whether Halloween is a pagan ritual dating back to Celtic Druids, as many believe, or actually a Christian creation is open to some debate. Boo: Either way, the first jack-o-lanterns were made from turnips, the fear…


Applied DNA makes its bed, U.S. retailers to jump in

By GREGORY ZELLER // Inspired by Applied DNA Sciences’ molecular-tagging technology, a global textiles manufacturer is climbing into bed with the “circular economy.” Actually, India-based GHCL Ltd. has already bedded the so-called circular economy (referencing a regenerative system in which waste and emissions are minimized by narrowing energy and material loops, mostly through recycling and manufacturing upgrades). The manufacturer is knee-deep in recycled materials, including entire linen lines formulated from recycled polyethylene terephthalate (you may…


At LineaRX, putting the horsepower behind the CAR T

By GREGORY ZELLER // Marking a big step in the war against cancer, a Stony Brook-based startup has initiated pre-clinical development of a non-viral, plasmid-free chimeric antigen receptor modified T-cell manufacturing platform. In English: A novel platform designed to develop and manufacture new pharmaceutical treatments, including treatments for different forms of cancer. The tech comes from LineaRx Inc., a wholly owned subsidiary that officially spun off from Stony Brook-based Applied DNA Sciences in September. Noting…


No. 345: Tinkerers, taxes, the Twist and Long Island’s economic-development wish list

Half-full: It’s Wednesday, dear readers, middle ground of another busy workweek on Long Island and around the globe. A warm welcome this Oct. 3 to new newsletter subscribers Jordan, Anita, Carole, Edward, Renee and Catherine – welcome to the show – and a happy National Techies Day to all. The annual observance, designed to inspire the next generation of techno-tinkerers, marks its 20th anniversary today. Donuts are optional: It’s also National Coffee With a Cop…


International partners looking to grow pot-tagging biz

By GREGORY ZELLER // Two months after introducing the world’s first DNA-based cannabis-tagging system, a Stony Brook biotech and its Canadian partner are looking to increase their stash of legal-marijuana growers. Supply-chain security and product-authentication specialist Applied DNA Sciences and Canadian pharmaceutical-solutions provider TheraCann International Benchmark Corp. this week announced an upgraded system designed to accommodate different sizes and type of growers – particularly larger-volume cannabis and hemp growers. The next generation of TheraCann International’s…


No. 341: Farming out east, divesting at Applied DNA and skipping the most important meal of the day (plus … Super Lawyers!)

Middle ground: Welcome to Wednesday, friends, and the midpoint of another busy workweek on beautiful Long Island. It’s Sept. 19 out there – Day 730 of the bitter Brangelina divorce proceedings, which kicked off when Angelina Jolie filed for divorce from Brad Pitt two years ago today. Stay tuned. Shofar, so good: It started at sundown Tuesday and lasts through sundown today, when they’ll be blowing the ceremonial ram’s horn at synagogues around the world….


With new spinoff, biotech goes all-in on DNA sales

By GREGORY ZELLER // A Stony Brook biotech with a growing international reputation for supply-chain security has spun off a new company focused on DNA modification and production. Stony Brook-based Applied DNA Sciences on Tuesday announced the formation of LineaRx Inc., a wholly owned subsidiary that will concentrate on commercializing the parent company’s extensive experience in the design, manufacture and chemical modification of DNA by large-scale polymerase chain reaction – big news for scientists working…